M&T Bank’s Gilead Sciences GILD Stock Holding History

M&T Bank’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.2M	Sell	180,912 -10,229	-5%	-$1.43M	0.09%	178
2025 Q4	$23.5M	Buy	191,141 +20,505	+12%	+$2.49M	0.08%	191
2025 Q3	$18.9M	Sell	170,636 -18,771	-10%	-$2.13M	0.06%	199
2025 Q2	$21M	Sell	189,407 -6,761	-3%	-$720K	0.07%	198
2025 Q1	$22M	Sell	196,168 -5,007	-2%	-$517K	0.08%	186
2024 Q4	$18.6M	Buy	201,175 +8,223	+4%	+$740K	0.06%	208
2024 Q3	$16.2M	Buy	192,952 +5,943	+3%	+$453K	0.05%	233
2024 Q2	$12.8M	Sell	187,009 -9,468	-5%	-$632K	0.04%	259
2024 Q1	$14.4M	Sell	196,477 -18,225	-8%	-$1.4M	0.05%	252
2023 Q4	$17.4M	Sell	214,702 -857	-0.4%	-$66.7K	0.06%	232
2023 Q3	$16.2M	Sell	215,559 -9,631	-4%	-$741K	0.06%	240
2023 Q2	$17.4M	Sell	225,190 -5,041	-2%	-$402K	0.06%	238
2023 Q1	$19.1M	Sell	230,231 -5,836	-2%	-$483K	0.07%	215
2022 Q4	$20.3M	Buy	236,067 +9,443	+4%	+$748K	0.08%	211
2022 Q3	$14M	Sell	226,624 -9,178	-4%	-$579K	0.06%	244
2022 Q2	$13.7M	Sell	235,802 -35,882	-13%	-$2.22M	0.06%	220
2022 Q1	$16.2M	Sell	271,684 -314,292	-54%	-$20.1M	0.07%	204
2021 Q4	$42.5M	Buy	585,976 +54,758	+10%	+$3.77M	0.18%	125
2021 Q3	$37.1M	Buy	531,218 +202,507	+62%	+$14.2M	0.17%	131
2021 Q2	$22.6M	Sell	328,711 -8,819	-3%	-$589K	0.1%	172
2021 Q1	$21.8M	Sell	337,530 -8,270	-2%	-$533K	0.09%	176
2020 Q4	$20.1M	Sell	345,800 -68,950	-17%	-$4.16M	0.09%	179
2020 Q3	$26.2M	Sell	414,750 -17,062	-4%	-$1.18M	0.13%	135
2020 Q2	$33.2M	Sell	431,812 -262,652	-38%	-$20.1M	0.18%	115
2020 Q1	$51.9M	Sell	694,464 -119,455	-15%	-$8.25M	0.31%	81
2019 Q4	$52.9M	Sell	813,919 -45,892	-5%	-$2.99M	0.25%	74
2019 Q3	$54.5M	Sell	859,811 -10,736	-1%	-$702K	0.27%	99
2019 Q2	$58.8M	Sell	870,547 -9,457	-1%	-$622K	0.31%	93
2019 Q1	$57.2M	Buy	880,004 +127,331	+17%	+$8.46M	0.3%	92
2018 Q4	$47.1M	Buy	752,673 +151,545	+25%	+$10.6M	0.27%	95
2018 Q3	$46.4M	Sell	601,128 -7,639	-1%	-$577K	0.23%	102
2018 Q2	$43.1M	Buy	608,767 +333,022	+121%	+$23.5M	0.23%	110
2018 Q1	$20.8M	Sell	275,745 -11,849	-4%	-$942K	0.11%	164
2017 Q4	$20.6M	Sell	287,594 -63,545	-18%	-$4.83M	0.11%	173
2017 Q3	$28.5M	Sell	351,139 -5,674	-2%	-$434K	0.15%	133
2017 Q2	$25.3M	Sell	356,813 -19,264	-5%	-$1.28M	0.15%	145
2017 Q1	$25.5M	Sell	376,077 -52,571	-12%	-$3.7M	0.15%	136
2016 Q4	$30.7M	Sell	428,648 -67,247	-14%	-$5M	0.19%	118
2016 Q3	$39.2M	Sell	495,895 -147,496	-23%	-$12M	0.25%	98
2016 Q2	$53.7M	Sell	643,391 -28,538	-4%	-$2.53M	0.36%	75
2016 Q1	$61.7M	Sell	671,929 -16,974	-2%	-$1.53M	0.42%	59
2015 Q4	$69.7M	Buy	688,903 +6,897	+1%	+$718K	0.46%	52
2015 Q3	$67M	Buy	682,006 +58,843	+9%	+$6.54M	0.46%	52
2015 Q2	$73M	Buy	623,163 +63,505	+11%	+$6.94M	0.44%	53
2015 Q1	$54.9M	Buy	559,658 +11,214	+2%	+$1.14M	0.34%	67
2014 Q4	$51.7M	Buy	548,444 +9,637	+2%	+$997K	0.32%	68
2014 Q3	$57.4M	Buy	538,807 +388,542	+259%	+$38M	0.37%	55
2014 Q2	$12.5M	Buy	150,265 +34,823	+30%	+$2.71M	0.52%	42
2014 Q1	$8.18M	Buy	115,442 +10,247	+10%	+$804K	0.34%	67
2013 Q4	$7.9M	Buy	105,195 +3,036	+3%	+$211K	0.33%	69
2013 Q3	$6.42M	Buy	102,159 +428	+0.4%	+$25.6K	0.31%	74
2013 Q2	$5.22M	Buy	+101,731	New	+$5.3M	0.25%	87

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

M&T Bank's GILD Position: Q1 2026 in Review

M&T Bank reduced its Gilead Sciences (GILD) stake by 5.4% in Q1 2026, selling an estimated $1.43M and leaving 180,912 shares worth $25.2M. The position accounts for 0.09% of the portfolio, ranked #178.

M&T Bank first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $73M in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

M&T Bank held 180,912 shares of Gilead Sciences worth $25.2M as of Q1 2026.
M&T Bank sold 10,229 Gilead Sciences shares in Q1 2026, an estimated $1.43M.
Gilead Sciences made up 0.09% of M&T Bank's portfolio in Q1 2026, its #178 holding.
M&T Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
M&T Bank's Gilead Sciences position peaked at $73M in Q2 2015.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.